Predictive Oncology announced the appointment of David S. Smith, JD, to the company's Board of Directors. Mr. Smith is a life sciences and corporate attorney, veteran biotech industry executive and leading authority on the
legal issues surrounding the therapeutic use of human tissue and cells. He has extensive transactional experience, venture financings and regulatory matters for life sciences companies and investors. Smith has been active in a number of trade organizations. He currently serves on the Board of Directors of Foundation for Cell and Gene Medicine. He is currently a Fellow and past member of the executive committee of Tissue Engineering and Regenerative Medicine International Society. He was additionally a member of the Board of Directors of the Pennsylvania Biotechnology Association and past officer of the Pittsburgh Tissue Engineering Initiative.